サマリー

GERDの世界市場 2023-2027
Technavioは、GERD市場をモニターしており、2022年から2027年の間に9,084万ドル、予測期間中のCAGRは3.4％で加速して成長すると予測しています。当レポートでは、GERD市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、高齢者人口の増加、生活習慣の乱れ、医薬品や栄養補助食品の過剰使用によって牽引されています。
TechnavioのGERD市場は以下のようにセグメント化されています：
投与経路別
- オーラル
- 非経口
タイプ別
- 制酸剤
- ピーピーアイ
- H2受容体拮抗薬
- プロキネティック医薬品
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、今後数年間におけるGERD市場の成長を促進する主な要因の一つとして、肥満の蔓延が挙げられています。また、電子商取引市場の拡大やGERDに対する意識の高まりは、市場の大きな需要につながると考えられます。
Technavioは、主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。当社のGERD市場に関するレポートは、以下の分野をカバーしています：
- GERD市場のサイジング
- GERD市場予測
- GERD市場の産業分析
Technavioの強固なベンダー分析は、お客様が市場での地位を向上させるのに役立つように設計されています。これに伴い、本レポートでは、Bayer AG、Alkem Laboratories Ltd.、Apotex Inc.、AstraZeneca Plc、Aurobindo Pharma Ltd.、Cipla Ltd.、Dr Reddys Laboratories Ltd.、Eisai Co., Ltd. などのGERD市場の主要ベンダー数社を詳細に分析しています。Ltd.、Fresenius SE and Co.KGaA、GlaxoSmithKline Plc、iNova Pharmaceuticals、Johnson and Johnson、Lupin Ltd.、Perrigo Co.Plc、Pfizer Inc.、SRS Life Sciences Pte.Ltd.、Sun Pharmaceutical Industries Ltd.、武田薬品工業(株)(以下、武田薬品)Ltd.、The Procter and Gamble Co.、Abbott Laboratoriesです。また、GERD市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gerd-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細なイメージを提示します。業界の主要なインフルエンサーを特定することにより、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global GERD market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global GERD market 2017 - 2021 ($ million)
o 4.2 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
o 4.3 Drug Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Drug Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Oral - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
o 6.4 Parenteral - Market size and forecast 2022-2027
o Exhibit 38: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 43: Chart on Type - Market share 2022-2027 (%)
o Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 45: Chart on Comparison by Type
o Exhibit 46: Data Table on Comparison by Type
o 7.3 Antacid - Market size and forecast 2022-2027
o Exhibit 47: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Antacid - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
o 7.4 PPI - Market size and forecast 2022-2027
o Exhibit 51: Chart on PPI - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on PPI - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on PPI - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on PPI - Year-over-year growth 2022-2027 (%)
o 7.5 H2 receptor antagonist drugs - Market size and forecast 2022-2027
o Exhibit 55: Chart on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
o 7.6 Pro-Kinetic drugs - Market size and forecast 2022-2027
o Exhibit 59: Chart on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Type
o Exhibit 63: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share by geography 2022-2027 (%)
o Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 105: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 112: Abbott Laboratories - Overview
o Exhibit 113: Abbott Laboratories - Business segments
o Exhibit 114: Abbott Laboratories - Key news
o Exhibit 115: Abbott Laboratories - Key offerings
o Exhibit 116: Abbott Laboratories - Segment focus
o 12.4 Alkem Laboratories Ltd.
o Exhibit 117: Alkem Laboratories Ltd. - Overview
o Exhibit 118: Alkem Laboratories Ltd. - Business segments
o Exhibit 119: Alkem Laboratories Ltd. - Key news
o Exhibit 120: Alkem Laboratories Ltd. - Key offerings
o Exhibit 121: Alkem Laboratories Ltd. - Segment focus
o 12.5 Apotex Inc.
o Exhibit 122: Apotex Inc. - Overview
o Exhibit 123: Apotex Inc. - Product / Service
o Exhibit 124: Apotex Inc. - Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 125: AstraZeneca Plc - Overview
o Exhibit 126: AstraZeneca Plc - Product / Service
o Exhibit 127: AstraZeneca Plc - Key news
o Exhibit 128: AstraZeneca Plc - Key offerings
o 12.7 Aurobindo Pharma Ltd.
o Exhibit 129: Aurobindo Pharma Ltd. - Overview
o Exhibit 130: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 131: Aurobindo Pharma Ltd. - Key offerings
o 12.8 Bayer AG
o Exhibit 132: Bayer AG - Overview
o Exhibit 133: Bayer AG - Business segments
o Exhibit 134: Bayer AG - Key news
o Exhibit 135: Bayer AG - Key offerings
o Exhibit 136: Bayer AG - Segment focus
o 12.9 Cipla Ltd.
o Exhibit 137: Cipla Ltd. - Overview
o Exhibit 138: Cipla Ltd. - Business segments
o Exhibit 139: Cipla Ltd. - Key news
o Exhibit 140: Cipla Ltd. - Key offerings
o Exhibit 141: Cipla Ltd. - Segment focus
o 12.10 Dr Reddys Laboratories Ltd.
o Exhibit 142: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 143: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 144: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 145: Dr Reddys Laboratories Ltd. - Segment focus
o 12.11 Eisai Co. Ltd.
o Exhibit 146: Eisai Co. Ltd. - Overview
o Exhibit 147: Eisai Co. Ltd. - Business segments
o Exhibit 148: Eisai Co. Ltd. - Key offerings
o Exhibit 149: Eisai Co. Ltd. - Segment focus
o 12.12 Fresenius SE and Co. KGaA
o Exhibit 150: Fresenius SE and Co. KGaA - Overview
o Exhibit 151: Fresenius SE and Co. KGaA - Business segments
o Exhibit 152: Fresenius SE and Co. KGaA - Key news
o Exhibit 153: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 154: Fresenius SE and Co. KGaA - Segment focus
o 12.13 GlaxoSmithKline Plc
o Exhibit 155: GlaxoSmithKline Plc - Overview
o Exhibit 156: GlaxoSmithKline Plc - Business segments
o Exhibit 157: GlaxoSmithKline Plc - Key offerings
o Exhibit 158: GlaxoSmithKline Plc - Segment focus
o 12.14 iNova Pharmaceuticals
o Exhibit 159: iNova Pharmaceuticals - Overview
o Exhibit 160: iNova Pharmaceuticals - Product / Service
o Exhibit 161: iNova Pharmaceuticals - Key offerings
o 12.15 Johnson and Johnson
o Exhibit 162: Johnson and Johnson - Overview
o Exhibit 163: Johnson and Johnson - Business segments
o Exhibit 164: Johnson and Johnson - Key news
o Exhibit 165: Johnson and Johnson - Key offerings
o Exhibit 166: Johnson and Johnson - Segment focus
o 12.16 Lupin Ltd.
o Exhibit 167: Lupin Ltd. - Overview
o Exhibit 168: Lupin Ltd. - Product / Service
o Exhibit 169: Lupin Ltd. - Key news
o Exhibit 170: Lupin Ltd. - Key offerings
o 12.17 Perrigo Co. Plc
o Exhibit 171: Perrigo Co. Plc - Overview
o Exhibit 172: Perrigo Co. Plc - Business segments
o Exhibit 173: Perrigo Co. Plc - Key news
o Exhibit 174: Perrigo Co. Plc - Key offerings
o Exhibit 175: Perrigo Co. Plc - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 176: Inclusions checklist
o Exhibit 177: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 178: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 179: Research methodology
o Exhibit 180: Validation techniques employed for market sizing
o Exhibit 181: Information sources
o 13.5 List of abbreviations
o Exhibit 182: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global GERD market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Drug Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Chart on Type - Market share 2022-2027 (%)
Exhibits44: Data Table on Type - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Type
Exhibits46: Data Table on Comparison by Type
Exhibits47: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Antacid - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on PPI - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on PPI - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on PPI - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on PPI - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Type ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share by geography 2022-2027 (%)
Exhibits66: Data Table on Market share by geography 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity by geography ($ million)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: Abbott Laboratories - Overview
Exhibits113: Abbott Laboratories - Business segments
Exhibits114: Abbott Laboratories - Key news
Exhibits115: Abbott Laboratories - Key offerings
Exhibits116: Abbott Laboratories - Segment focus
Exhibits117: Alkem Laboratories Ltd. - Overview
Exhibits118: Alkem Laboratories Ltd. - Business segments
Exhibits119: Alkem Laboratories Ltd. - Key news
Exhibits120: Alkem Laboratories Ltd. - Key offerings
Exhibits121: Alkem Laboratories Ltd. - Segment focus
Exhibits122: Apotex Inc. - Overview
Exhibits123: Apotex Inc. - Product / Service
Exhibits124: Apotex Inc. - Key offerings
Exhibits125: AstraZeneca Plc - Overview
Exhibits126: AstraZeneca Plc - Product / Service
Exhibits127: AstraZeneca Plc - Key news
Exhibits128: AstraZeneca Plc - Key offerings
Exhibits129: Aurobindo Pharma Ltd. - Overview
Exhibits130: Aurobindo Pharma Ltd. - Product / Service
Exhibits131: Aurobindo Pharma Ltd. - Key offerings
Exhibits132: Bayer AG - Overview
Exhibits133: Bayer AG - Business segments
Exhibits134: Bayer AG - Key news
Exhibits135: Bayer AG - Key offerings
Exhibits136: Bayer AG - Segment focus
Exhibits137: Cipla Ltd. - Overview
Exhibits138: Cipla Ltd. - Business segments
Exhibits139: Cipla Ltd. - Key news
Exhibits140: Cipla Ltd. - Key offerings
Exhibits141: Cipla Ltd. - Segment focus
Exhibits142: Dr Reddys Laboratories Ltd. - Overview
Exhibits143: Dr Reddys Laboratories Ltd. - Business segments
Exhibits144: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits145: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits146: Eisai Co. Ltd. - Overview
Exhibits147: Eisai Co. Ltd. - Business segments
Exhibits148: Eisai Co. Ltd. - Key offerings
Exhibits149: Eisai Co. Ltd. - Segment focus
Exhibits150: Fresenius SE and Co. KGaA - Overview
Exhibits151: Fresenius SE and Co. KGaA - Business segments
Exhibits152: Fresenius SE and Co. KGaA - Key news
Exhibits153: Fresenius SE and Co. KGaA - Key offerings
Exhibits154: Fresenius SE and Co. KGaA - Segment focus
Exhibits155: GlaxoSmithKline Plc - Overview
Exhibits156: GlaxoSmithKline Plc - Business segments
Exhibits157: GlaxoSmithKline Plc - Key offerings
Exhibits158: GlaxoSmithKline Plc - Segment focus
Exhibits159: iNova Pharmaceuticals - Overview
Exhibits160: iNova Pharmaceuticals - Product / Service
Exhibits161: iNova Pharmaceuticals - Key offerings
Exhibits162: Johnson and Johnson - Overview
Exhibits163: Johnson and Johnson - Business segments
Exhibits164: Johnson and Johnson - Key news
Exhibits165: Johnson and Johnson - Key offerings
Exhibits166: Johnson and Johnson - Segment focus
Exhibits167: Lupin Ltd. - Overview
Exhibits168: Lupin Ltd. - Product / Service
Exhibits169: Lupin Ltd. - Key news
Exhibits170: Lupin Ltd. - Key offerings
Exhibits171: Perrigo Co. Plc - Overview
Exhibits172: Perrigo Co. Plc - Business segments
Exhibits173: Perrigo Co. Plc - Key news
Exhibits174: Perrigo Co. Plc - Key offerings
Exhibits175: Perrigo Co. Plc - Segment focus
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations